18:03 16 December 2015
The Advertising Standards Authority has received 12 complaints about Nurofen Express advert, which claim that it "targets the real source of most headaches faster." The ASA is now probing the marketing of the said product after some consumers felt that it was misleading.
"Complainants have challenged whether the ad is misleading because it implies that the product directly targets muscles in the head. They've also challenged whether the claim 'gives you faster headache relief than standard paracetamol or ibuprofen' is misleading."
The ASA stressed that it investigates marketing of products, not the product itself.
"The products are regulated by health regulators such as the Medicines & Healthcare products Regulatory Agency (MHRA)," the ASA added.